作者：
Kenna, J. Gerry [1]
;
Stahl, Simone H. [2]
;
Eakins, Julie A. [3]
;
Foster, Alison J. [4]
;
Andersson, Linda C. [5]
;
Bergare, Jonas [6]
;
Billger, Martin [7]
;
Elebring, Marie [8]
;
Elmore, Charles S. ;
Thompson, Richard A.
作者单位：
AstraZeneca R& Alderley Pk, Drug Safety & Metab, Discovery Safety, Macclesfield, Cheshire, England
[1]
AstraZeneca R& Alderley Pk, Drug Safety & Metab, Translat Safety, Macclesfield, Cheshire, England
[2]
iMED AstraZeneca R&D Molndal, Resp Inflammat & Autoimmun, SE-43183 Molndal, Sweden
[3]
iMED AstraZeneca R&D Molndal, Cardiovasc & Metab Dis, DMPK, SE-43183 Molndal, Sweden
[4]
Drug Safety Consultant, Macclesfield, Cheshire, England
[5]
AstraZeneca R&D, Regulatory Safety Drug Safety & Metab, Molndal, Sweden
[6]
AstraZeneca R& Alderley Pk, Drug Safety & Metab, DMPK, Macclesfield, Cheshire, England
[7]
AstraZeneca R&D, Drug Safety & Metab, DMPK, Molndal, Sweden
[8]
发布时间
2017-04-06
换一批
换一批
